Clinical response to futibatinib in intrahepatic cholangiocarcinoma with acquired resistance to fibroblast growth factor receptor 2 inhibitors

被引：0
|
作者：
Casalino, S. [1 ]
Gerdes, C. [2 ]
Saborowski, A. [2 ]
Quinzii, A. [1 ]
Zecchetto, C. [1 ]
Sordo, A. [3 ]
Messineo, L. [1 ]
Leta, L. C. [1 ]
Lucin, E. [1 ]
Mendo, L. [1 ]
Pietrobono, S. [1 ]
Vogel, A. [4 ]
Melisi, D. [1 ]
机构：
[1] Univ Verona, Digest Mol Clin Oncol Res Unit, Verona, Italy
[2] MHH, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany
[3] Univ Padua, Unit Biostat Epidemiol & Publ Hlth, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Padua, Italy
[4] Princess Margaret Canc Ctr, Div Gastroenterol & Hepatol, Toronto, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.447
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
304P
引用
收藏
页码：S128 / S129
页数：2
相关论文
共 50 条
  • [31] Fibroblast Growth Factor Receptor Inhibitors and Nonuremic Calciphylaxis
    Hirner, Jesse
    Cleary, James M.
    Sheets, Anthony
    Murphy, George
    LeBoeuf, Nicole
    JAMA DERMATOLOGY, 2021, 157 (01) : 119 - 121
  • [32] PTEN PHOSPHORYLATION BY FIBROBLAST GROWTH FACTOR RECEPTORS AND SRC MEDIATES RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN GLIOMA
    Furnari, Frank
    Fenton, Timothy
    Nathanson, David
    de Alberquerque, Claudio Ponte
    Kuga, Daisuke
    Wanami, Akio
    Dang, Julie
    Yang, Huijun
    Tanaka, Kazuhiro
    Gao, Lu
    Oba-Shinjo, Sueli
    Uno, Miyuki
    Inda, Maria-del-Mar
    Bachoo, Robert
    James, C. David
    DePinho, Ronald
    Vandenberg, Scott
    Zhou, Huilin
    Marie, Suely
    Mischel, Paul
    Cavenee, Webster
    NEURO-ONCOLOGY, 2011, 13 : 10 - 10
  • [33] Placental growth factor promotes tumor desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma
    Aoki, Shuichi
    Kobayashi, Minoru
    Kajiwara, Taiki
    Ariake, Kyohei
    Yamamura, Akihiro
    Kawaguchi, Kei
    Karasawa, Hideaki
    Ohtsuka, Hideo
    Mizuma, Masamichi
    Ohnuma, Shinobu
    Unno, Michiaki
    CANCER SCIENCE, 2022, 113 : 1264 - 1264
  • [34] Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations
    Lee, Patrick C.
    Hendifar, Andrew
    Osipov, Arsen
    Cho, May
    Li, Daneng
    Gong, Jun
    CANCERS, 2021, 13 (07)
  • [35] Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma
    Aoki, Shuichi
    Inoue, Koetsu
    Klein, Sebastian
    Halvorsen, Stefan
    Chen, Jiang
    Matsui, Aya
    Nikmaneshi, Mohammad R.
    Kitahara, Shuji
    Hato, Tai
    Chen, Xianfeng
    Kawakubo, Kazumichi
    Nia, Hadi T.
    Chen, Ivy
    Schanne, Daniel H.
    Mamessier, Emilie
    Shigeta, Kohei
    Kikuchi, Hiroto
    Ramjiawan, Rakesh R.
    Schmidt, Tyge C. E.
    Iwasaki, Masaaki
    Yau, Thomas
    Hong, Theodore S.
    Quaas, Alexander
    Plum, Patrick S.
    Dima, Simona
    Popescu, Irinel
    Bardeesy, Nabeel
    Munn, Lance L.
    Borad, Mitesh J.
    Sassi, Slim
    Jain, Rakesh K.
    Zhu, Andrew X.
    Duda, Dan G.
    GUT, 2022, 71 (01) : 185 - 193
  • [36] Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer
    Turcin Saridogan
    Argun Akcakanat
    Ming Zhao
    Kurt W. Evans
    Erkan Yuca
    Stephen Scott
    Bryce P. Kirby
    Xiaofeng Zheng
    Min Jin Ha
    Huiqin Chen
    Patrick K. S. Ng
    Timothy P. DiPeri
    Gordon B. Mills
    Jordi Rodon Ahnert
    Senthil Damodaran
    Funda Meric-Bernstam
    Scientific Reports, 13
  • [37] Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer
    Saridogan, Turcin
    Akcakanat, Argun
    Zhao, Ming
    Evans, Kurt W.
    Yuca, Erkan
    Scott, Stephen
    Kirby, Bryce P.
    Zheng, Xiaofeng
    Ha, Min Jin
    Chen, Huiqin
    Ng, Patrick K. S.
    DiPeri, Timothy P.
    Mills, Gordon B.
    Ahnert, Jordi Rodon
    Damodaran, Senthil
    Meric-Bernstam, Funda
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [38] Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398
    Datta, Jharna
    Damodaran, Senthilkumar
    Parks, Hannah
    Ocrainiciuc, Cristina
    Miya, Jharna
    Yu, Lianbo
    Gardner, Elijah P.
    Samorodnitsky, Eric
    Wing, Michele R.
    Bhatt, Darshna
    Hays, John
    Reeser, Julie W.
    Roychowdhury, Sameek
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (04) : 614 - 624
  • [39] Fibroblast Growth Factor Receptor (FGFR)3 sustains acquired resistance to trastuzumab in gastric cancer patients
    Piro, G.
    Carbone, C.
    Cataldo, I.
    Di Nicolantonio, F.
    Giacopuzzi, S.
    Boschi, F.
    Zanotto, M.
    Merz, V.
    Mina, M. M.
    Sbarbati, A.
    De Manzoni, G.
    Scarpa, A.
    Tortora, G.
    Melisi, D.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S42 - S43
  • [40] Painful Eruptions in a Patient With Cholangiocarcinoma Treated With Fibroblast Growth Factor Receptor Inhibitor
    Wylie, Natasha S.
    Sokumbi, Olayemi
    Starr, Jason S.
    JAMA ONCOLOGY, 2021, 7 (12) : 1891 - 1892
12345